Zynerba receives FDA guidance for Phase 3 trial design for Zygel in rare genetic disorder
06 May 2021 - 6:46AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From Apr 2024 to May 2024
Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From May 2023 to May 2024